re: Ann: ELX announces further results for 2R... More useful evidence for the effectiveness of 2RT. Provides some nice blue sky appeal if it can make its way to commercialization.
In the meantime sales growth looks to be returning in the core business which is good news.
All in all an interesting play on the ageing population thematic.
Ann: ELX announces further results for 2RT treatm, page-2
Add EYE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $44.66M | |||
| Open | High | Low | Value | Volume |
| 19.5¢ | 20.5¢ | 19.5¢ | $45.91K | 228.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 121054 | 19.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 14492 | 1 |
View Market Depth
| Last trade - 12.13pm 05/09/2024 (20 minute delay) ? |
| EYE (ASX) Chart |